<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01156948</url>
  </required_header>
  <id_info>
    <org_study_id>WenzhouMC</org_study_id>
    <nct_id>NCT01156948</nct_id>
  </id_info>
  <brief_title>Misoprostol For Nulliparous Women Before Hysteroscopy</brief_title>
  <official_title>Comparison of Vaginal Versus Oral Misoprostol for Nulliparous Women Prior to Operative Hysteroscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wenzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wenzhou Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the impact of 400-microgram self-administered vaginal versus self-administered
      oral misoprostol at home on preoperative cervical ripening in nulliparous women prior to
      outpatient hysteroscopy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There is no consensus on the effect of misoprostol on cervical ripening for nulliparous
      women. The aim of the study is to compare the impact of 400-microgram self-administered
      vaginal versus self-administered oral misoprostol at home on preoperative cervical ripening
      in nulliparous women prior to outpatient hysteroscopy.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2008</start_date>
  <completion_date type="Anticipated">December 2011</completion_date>
  <primary_completion_date type="Anticipated">August 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cervical width</measure>
    <time_frame>one day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>side effects</measure>
    <time_frame>one day</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Cervical Ripening</condition>
  <arm_group>
    <arm_group_label>vaginal misoprostol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>vaginal misoprostol was administered to this group of nulliparous women</description>
  </arm_group>
  <arm_group>
    <arm_group_label>oral misoprostol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>oral misoprostol</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>misoprostol</intervention_name>
    <description>400ug vaginally the day before surgery</description>
    <arm_group_label>vaginal misoprostol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>oral misoprostol</intervention_name>
    <description>400ug misoprostol orally the day before the surgery</description>
    <arm_group_label>oral misoprostol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  nulliparous women who are referred to outpatient hysteroscopy and who have given
             informed consent will be eligible for study recruitment.

        Exclusion Criteria:

          -  women with a known allergy to misoprostol.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Feng Lin</last_name>
    <role>Principal Investigator</role>
    <affiliation>the 1st affiliated hospital of Wenzhou Medical College</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>the 1st Affiliated Hospital of Wenzhou Medical College</name>
      <address>
        <city>Wenzhou</city>
        <state>Zhejiang</state>
        <zip>325000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Feng Lin, MD</last_name>
      <email>linfeng983023@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Feng Lin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 2, 2010</study_first_submitted>
  <study_first_submitted_qc>July 2, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 5, 2010</study_first_posted>
  <last_update_submitted>July 7, 2010</last_update_submitted>
  <last_update_submitted_qc>July 7, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 8, 2010</last_update_posted>
  <responsible_party>
    <name_title>Feng Lin</name_title>
    <organization>the 1st Affiliated Hospital of Wenzhou Medical College</organization>
  </responsible_party>
  <keyword>misoprostol</keyword>
  <keyword>nulliparous</keyword>
  <keyword>hysteroscopy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Misoprostol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

